Brian Feroldi

Brian Feroldi


Brian Feroldi has been covering the healthcare and technology industries for the Motley Fool since 2015. Brian's investing goal is to find the highest quality companies that he can find, buy them, and then to sit back and let compounding work its magic. See all of his articles here and make sure you follow him on Twitter.

Recent articles

Why Aptinyx Stock Soared on Friday

Shares rose in response to news that a large investment management company has purchased a significant ownership position.

3 Aesthetics Stocks to Watch

Aesthetics surgery is a big market, and these three companies are positioned to win from its growth.

5 Top Stocks to Buy in December

Looking for values in today's pricey stock market? Start your search with these five businesses.

Why Abiomed Stock Is Falling Today

Shares slump after a pair of clinical studies raises new questions about the safety and cost effectiveness of Abiomed's family of heart pumps. Here are the must-know details.

3 Medtech Earnings Winners

Guardant, Dexcom, and Insulet nailed their quarters and have massive room to grow in the long run, too.